[1] AFRA S, MATIN MM. Potential of mesenchymal stem cells for bioengineered blood vessels in comparison with other eligible cell sources. Cell Tissue Res. 2020;380(1):1-13.
[2] BIAN Q, CHEN J, WENG Y, et al. Endothelialization strategy of implant materials surface: the newest research in recent 5 years. J Appl Biomater Funct Mater. 2022;20:22808000221105332.
[3] ASLANI S, KABIRI M, HOSSEINZADEH S, et al. The applications of heparin in vascular tissue engineering. Microvasc Res. 2020;131:104027.
[4] CHEN SG, UGWU F, LI WC, et al. Vascular Tissue Engineering: advanced Techniques and Gene Editing in Stem Cells for Graft Generation. Tissue Eng Part B Rev. 2021;27(1):14-28.
[5] NIKLASON LE, LAWSON JH. Bioengineered human blood vessels. Science. 2020; 370(6513):eaaw8682.
[6] ARUTYUNYAN I, FATKHUDINOV T, SUKHIKH G. Umbilical cord tissue cryopreservation: a short review. Stem Cell Res Ther. 2018;9(1):236.
[7] KIRKTON RD, PRICHARD HL, SANTIAGO-MAYSONET M, et al. Susceptibility of ePTFE vascular grafts and bioengineered human acellular vessels to infection. J Surg Res. 2018;221:143-151.
[8] JOUDA H, LARREA MURILLO L, WANG T. Current progress in vascular engineering and its clinical applications. Cells. 2022;11(3):493.
[9] NAEGELI KM, KURAL MH, LI Y, et al. Bioengineering human tissues and the future of vascular replacement. Circ Res. 2022;131(1):109-126.
[10] SÁNCHEZ PF, BREY EM, BRICEÑO JC. Endothelialization mechanisms in vascular grafts. J Tissue Eng Regen Med. 2018;12(11):2164-2178.
[11] TALACUA H, SMITS AI, MUYLAERT DE, et al. In situ tissue engineering of functional small-diameter blood vessels by host circulating cells only. Tissue Eng Part A. 2015;21(19-20):2583-2594.
[12] JANA S. Endothelialization of cardiovascular devices. Acta Biomater. 2019;99: 53-71.
[13] FALAY M, AKTAS S. Endothelial progenitor cells (EPC) count by multicolor flow cytometry in healthy individuals and diabetes mellitus (DM) patients. Clin Lab. 2016;62(11):2161-2166.
[14] 田玲,周诺.内皮祖细胞生物学特性的研究进展[J].中国比较医学杂志, 2019,29(10):112-116,130.
[15] SU LC, XU H, TRAN RT, et al. In situ re-endothelialization via multifunctional nanoscaffolds. ACS Nano. 2014;8(10):10826-10836.
[16] DAHAN N, SARIG U, BRONSHTEIN T, et al. Dynamic autologous reendothelialization of small-caliber arterial extracellular matrix: a preclinical large animal study. Tissue Eng Part A. 2017;23(1-2):69-79.
[17] JANG S, COLLIN DE L’HORTET A, SOTO-GUTIERREZ A. Induced pluripotent stem cell-derived endothelial cells: overview, current advances, applications, and future directions. Am J Pathol. 2019;189(3):502-512.
[18] LUO J, QIN L, PARK J, et al. Readily available tissue-engineered vascular grafts derived from human induced pluripotent stem cells. Circ Res. 2022;130(6): 925-927.
[19] ZOU T, FAN J, FARTASH A, et al. Cell-based strategies for vascular regeneration. J Biomed Mater Res A. 2016;104(5):1297-1314.
[20] SHI X, HE L, ZHANG SM, et al. Human iPS cell-derived tissue engineered vascular graft: recent advances and future directions. Stem Cell Rev Rep. 2021;17(3): 862-877.
[21] CAI Q, LIAO W, XUE F, et al. Selection of different endothelialization modes and different seed cells for tissue-engineered vascular graft. Bioact Mater. 2021; 6(8):2557-2568.
[22] KRAUS X, VAN DE FLIERDT E, RENZELMANN J, et al. Peripheral blood derived endothelial colony forming cells as suitable cell source for pre-endothelialization of arterial vascular grafts under dynamic flow conditions. Microvasc Res. 2022; 143(1095-9319 (Electronic)):104402.
[23] MEDINA RJ, BARBER CL, SABATIER F, et al. Endothelial progenitors: a consensus statement on nomenclature. Stem Cells Transl Med. 2017;6(5):1316-1320.
[24] CHOPRA H, HUNG MK, KWONG DL, et al. Insights into endothelial progenitor cells: origin, classification, potentials, and prospects. Stem Cells Int. 2018;2018: 9847015.
[25] BRAGHIROLLI DI, HELFER VE, CHAGASTELLES PC, et al. Electrospun scaffolds functionalized with heparin and vascular endothelial growth factor increase the proliferation of endothelial progenitor cells. Biomed Mater. 2017;12(2):025003.
[26] MUNISWAMI DM, REDDY LVK, AMIRTHAM SM, et al. Endothelial progenitor/stem cells in engineered vessels for vascular transplantation. J Mater Sci Mater Med. 2020;31(12):119.
[27] GLYNN JJ, HINDS MT. Endothelial outgrowth cells regulate coagulation, platelet accumulation, and respond to tumor necrosis factor similar to carotid endothelial cells. Tissue Eng Part A. 2015;21(1-2):174-182.
[28] GLYNN JJ, HINDS MT. Endothelial outgrowth cells: function and performance in vascular grafts. Tissue Eng Part B Rev. 2014;20(4):294-303.
[29] 汪川,李京倖,辛毅,等.人脱细胞脐动脉支架与兔骨髓内皮祖细胞构建组织工程血管的实验研究[J].心肺血管病杂志,2014,33(4):586-591.
[30] GUO HF, DAI WW, QIAN DH, et al. A simply prepared small-diameter artificial blood vessel that promotes in situ endothelialization. Acta Biomater. 2017;54: 107-116.
[31] CHEN X, WANG J, AN Q, et al. Electrospun poly (L-lactic acid-co-varepsilon-caprolactone) fibers loaded with heparin and vascular endothelial growth factor to improve blood compatibility and endothelial progenitor cell proliferation. Colloids Surf B Biointerfaces. 2015;128:106-114.
[32] MELCHIORRI AJ, BRACAGLIA LG, KIMERER LK, et al. In vitro endothelialization of biodegradable vascular grafts via endothelial progenitor cell seeding and maturation in a tubular perfusion system bioreactor. Tissue Eng Part C Methods. 2016;22(7):663-670.
[33] KANG TY, LEE JH, KIM BJ, et al. In vivo endothelization of tubular vascular grafts through in situ recruitment of endothelial and endothelial progenitor cells by RGD-fused mussel adhesive proteins. Biofabrication. 2015;7(1):015007.
[34] 吴杨霄.调控干细胞能量代谢在体构建小口径组织工程血管[D].重庆:第三军医大学,2015.
[35] 杨婧媛. 表面修饰诱导原位抗凝及促内皮化的组织工程血管构建[D].重庆:陆军军医大学,2019.
[36] CHEN W, XIAO L, BAI J, et al. The promotion of tissue engineering blood vessel patency by CGS21680 through regulating pro-inflammatory activities of endothelial progenitor cell. J Biomed Mater Res A. 2018;106(10):2634-2642.
[37] HAO D, FAN Y, XIAO W, et al. Rapid endothelialization of small diameter vascular grafts by a bioactive integrin-binding ligand specifically targeting endothelial progenitor cells and endothelial cells. Acta Biomater. 2020;108(1878-7568 (Electronic)):178-193.
[38] THITIWUTHIKIAT P, II M, SAITO T, et al. A vascular patch prepared from Thai silk fibroin and gelatin hydrogel incorporating simvastatin-micelles to recruit endothelial progenitor cells. Tissue Eng Part A. 2015;21(7-8):1309-1319.
[39] LI N, RICKEL AP, HONG Z. On-site differentiation of human mesenchymal stem cells into vascular cells on extracellular matrix scaffold under mechanical stimulations for vascular tissue engineering. Methods Mol Biol. 2022;2375 (1940-6029 (Electronic)):35-46.
[40] DHULEKAR J, SIMIONESCU A. Challenges in vascular tissue engineering for diabetic patients. Acta Biomater. 2018;70:25-34.
[41] 刘明颖. 海藻酸钙微纤维中包封的骨髓间充质干细胞被诱导向血管内皮分化的研究[D]. 重庆:重庆大学,2018.
[42] 艾文佳,李杰,李雯,等.调节ALK5受体活化水平优化间充质干细胞的内皮分化及组织工程血管的应用[J]. 中山大学学报(医学科学版),2013,34(2): 207-214.
[43] XIANG Q, HONG D, LIAO Y, et al. Overexpression of gremlin1 in mesenchymal stem cells improves hindlimb ischemia in mice by enhancing cell survival. J Cell Physiol. 2017;232(5):996-1007.
[44] SHAFIQ M, JUNG Y, KIM SH. Covalent immobilization of stem cell inducing/recruiting factor and heparin on cell-free small-diameter vascular graft for accelerated in situ tissue regeneration. J Biomed Mater Res A. 2016;104(6): 1352-1371.
[45] SHAFIQ M, ZHANG Q, ZHI D, et al. In Situ blood vessel regeneration using SP (Substance P) and SDF (Stromal cell-derived factor)-1alpha peptide eluting vascular grafts. Arterioscler Thromb Vasc Biol. 2018;38(7):e117-e134.
[46] BERTANHA M, MOROZ A, ALMEIDA R, et al. Tissue-engineered blood vessel substitute by reconstruction of endothelium using mesenchymal stem cells induced by platelet growth factors. J Vasc Surg. 2014;59(6):1677-1685.
[47] FREIMAN A, SHANDALOV Y, ROZENFELD D, et al. Adipose-derived endothelial and mesenchymal stem cells enhance vascular network formation on three-dimensional constructs in vitro. Stem Cell Res Ther. 2016;7:5.
[48] LIN CH, LU JH, HSIA K, et al. The antithrombotic function of sphingosine-1-phosphate on human adipose-stem-cell-recellularized tissue engineered vascular graft in vitro. Int J Mol Sci. 2019;20(20):5218.
[49] POLICHA A, ZHANG P, CHANG L, et al. Endothelial differentiation of diabetic adipose-derived stem cells. J Surg Res. 2014;192(2):656-663.
[50] LIN CH, HSIA K, TSAI CH, et al. Decellularized porcine coronary artery with adipose stem cells for vascular tissue engineering. Biomed Mater. 2019;14(4):045014.
[51] MCILHENNY S, ZHANG P, TULENKO T, et al. eNOS transfection of adipose-derived stem cells yields bioactive nitric oxide production and improved results in vascular tissue engineering. J Tissue Eng Regen Med. 2015;9(11):1277-1285.
[52] HASKETT DG, SALEH KS, LORENTZ KL, et al. An exploratory study on the preparation and evaluation of a “same-day” adipose stem cell-based tissue-engineered vascular graft. J Thorac Cardiovasc Surg. 2018;156(5):1814-1822 e1813.
[53] TSENG YC, ROAN JN, HO YC, et al. An in vivo study on endothelialized vascular grafts produced by autologous biotubes and adipose stem cells (ADSCs). J Mater Sci Mater Med. 2017;28(10):166.
[54] IACOBAZZI D, SWIM MM, ALBERTARIO A, et al. Thymus-derived mesenchymal stem cells for tissue engineering clinical-grade cardiovascular grafts. Tissue Eng Part A. 2018;24(9-10):794-808.
[55] KOOBATIAN MT, LIANG MS, SWARTZ DD, et al. Differential effects of culture senescence and mechanical stimulation on the proliferation and leiomyogenic differentiation of MSC from different sources: implications for engineering vascular grafts. Tissue Eng Part A. 2015;21(7-8):1364-1375.
[56] GAO Y, LIU F, ZHANG L, et al. Acellular blood vessels combined human hair follicle mesenchymal stem cells for engineering of functional arterial grafts. Ann Biomed Eng. 2014;42(10):2177-2189.
[57] PFEIFFER D, WANKHAMMER K, STEFANITSCH C, et al. Amnion-derived mesenchymal stem cells improve viability of endothelial cells exposed to shear stress in ePTFE grafts. Int J Artif Organs. 2019;42(2):80-87.
[58] 王俊力,许慧芳,冯莉,等.不同组织来源间充质干细胞向血管内皮细胞诱导分化的研究与进展[J].中国组织工程研究,2016,20(36):5466-5472.
[59] WEBER B, KEHL D, BLEUL U, et al. In vitro fabrication of autologous living tissue-engineered vascular grafts based on prenatally harvested ovine amniotic fluid-derived stem cells. J Tissue Eng Regen Med. 2016;10(1):52-70.
[60] WANG JN, KAN CD, LIN SH, et al. Potential of autologous progenitor cells and decellularized porcine artery matrix in construction of tissue-engineered vascular grafts. Organogenesis. 2021;17(3-4):72-84.
[61] SHERMAN SE, KULJANIN M, COOPER TT, et al. High aldehyde dehydrogenase activity identifies a subset of human mesenchymal stromal cells with vascular regenerative potential. Stem Cells. 2017;35(6):1542-1553.
[62] BAI X, XI J, BI Y, et al. TNF-alpha promotes survival and migration of MSCs under oxidative stress via NF-kappaB pathway to attenuate intimal hyperplasia in vein grafts. J Cell Mol Med. 2017;21(9):2077-2091.
[63] LA A, TRANQUILLO RT. Shear conditioning of adipose stem cells for reduced platelet binding to engineered vascular grafts. Tissue Eng Part A. 2018;24(15-16): 1242-1250.
[64] JIAO Y, ZHANG Y, XIAO Y, et al. The crescendo pulse frequency of shear stress stimulates the endothelialization of bone marrow mesenchymal stem cells on the luminal surface of decellularized scaffold in the bioreactor. Bioengineered. 2022;13(3):7925-7938.
[65] ZHAO D, SUN Y, WEI X, et al. cIAP1 attenuates shear stress-induced hBMSC apoptosis for tissue-engineered blood vessels through the inhibition of the mitochondrial apoptosis pathway. Life Sci. 2015;137:81-88.
[66] CHEN H, ZHANG Z, WANG Z, et al. Stage-specific regulation of Gremlin1 on the differentiation and expansion of human urinary induced pluripotent stem cells into endothelial progenitors. J Cell Mol Med. 2020;24(14):8018-8030.
[67] CONG X, ZHANG SM, BATTY L, et al. Application of human induced pluripotent stem cells in generating tissue-engineered blood vessels as vascular grafts. Stem Cells Dev. 2019;28(24):1581-1594.
[68] LUO J, SHI X, LIN Y, et al. Efficient differentiation of human induced pluripotent stem cells into endothelial cells under xenogeneic-free conditions for vascular tissue engineering. Acta Biomater. 2021;119:184-196.
[69] BEZENAH JR, KONG YP, PUTNAM AJ. Evaluating the potential of endothelial cells derived from human induced pluripotent stem cells to form microvascular networks in 3D cultures. Sci Rep. 2018;8(1):2671.
[70] KLEIN D. iPSCs-based generation of vascular cells: reprogramming approaches and applications. Cell Mol Life Sci. 2018;75(8):1411-1433.
[71] SIVARAPATNA A, GHAEDI M, LE AV, et al. Arterial specification of endothelial cells derived from human induced pluripotent stem cells in a biomimetic flow bioreactor. Biomaterials. 2015;53:621-633.
[72] ATCHISON L, ABUTALEB NO, SNYDER-MOUNTS E, et al. iPSC-derived endothelial cells affect vascular function in a tissue-engineered blood vessel model of hutchinson-gilford progeria syndrome. Stem Cell Reports. 2020;14(2):325-337.
[73] SAMUEL R, DAHERON L, LIAO S, et al. Generation of functionally competent and durable engineered blood vessels from human induced pluripotent stem cells. Proc Natl Acad Sci U S A. 2013;110(31):12774-12779.
[74] SUNDARAM S, ONE J, SIEWERT J, et al. Tissue-engineered vascular grafts created from human induced pluripotent stem cells. Stem Cells Transl Med. 2014;3(12):1535-1543.
[75] JI J, XU H, LI C, et al. Small-caliber tissue-engineered vascular grafts based on human-induced pluripotent stem cells: progress and challenges. Tissue Eng Part B Rev. 2023;29(4):441-455.
[76] GENERALI M, CASANOVA EA, KEHL D, et al. Autologous endothelialized small-caliber vascular grafts engineered from blood-derived induced pluripotent stem cells. Acta Biomater. 2019;97:333-343.
[77] 夏振伟,王纪文,李向东,等.低氧条件下诱导人胚胎干细胞向血管内皮前体细胞的分化[J].中国组织工程研究,2014,18(45):7255-7259.
[78] CAMPAGNOLO P, TSAI TN, HONG X, et al. c-Kit+ progenitors generate vascular cells for tissue-engineered grafts through modulation of the Wnt/Klf4 pathway. Biomaterials. 2015;60:53-61.
[79] SUNDARAM S, ECHTER A, SIVARAPATNA A, et al. Small-diameter vascular graft engineered using human embryonic stem cell-derived mesenchymal cells. Tissue Eng Part A. 2014;20(3-4):740-750.
[80] ZHAO L, CHEN HL, XIE LQ, et al. Modification of decellularized vascular scaffold with conditioned medium to enhance cell reseeding. J Biomater Sci Polym Ed. 2016;27(11):1115-1125.
[81] WANG L, HU J, SOREK CE, et al. Fabrication of tissue-engineered vascular grafts with stem cells and stem cell-derived vascular cells. Expert Opin Biol Ther. 2016; 16(3):317-330. |